Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of administration route on nanocarrier biodistribution in a murine colitis model

Journal of Experimental Nanoscience(2022)10.1080/17458080.2022.2134563Source: DataRank Database

Impact of administration route on nanocarrier biodistribution in a murine colitis model is a research paper published in Journal of Experimental Nanoscience (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.51)OA: goldTopics (30)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Hongping Deng ORCID,Brittany L. Kleszynski,Tzu-Wen Cross ORCID,Christian J. Konopka ORCID,Lawrence W. Dobrucki ORCID

Live enrichment

PubMed:36968097 PMC:PMC10038121 OpenAlex:https://openalex.org/W4306929546

National Institutes of Health

Grant: R01 DK112251

NCI NIH HHS

Grant: R01 CA234025

National Institutes of Health

Grant: 1R01DK112251-01

Targeted Drug Delivery to Adipose Tissue Macrophages in Obesity

FWCI

0.51

Citation Percentile

0.7%

Citation Trend

2024

2025

goldLicense: cc-by

journalhttps://doi.org/10.1080/17458080.2022.2134563

publisherhttps://doi.org/10.1080/17458080.2022.2134563

publisherhttps://www.tandfonline.com/doi/pdf/10.1080/17458080.2022.2134563

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36968097

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10038121

Fields of Study

Inflammatory Bowel DiseasePregnancy and Medication ImpactAbdominal vascular conditions and treatments0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

NanocarriersBiodistributionColitisInflammatory bowel diseaseMedicineInflammationPositron emission tomographyPharmacologyPathologyImmunologyGastroenterologyDiseaseNuclear medicineIn vivoBiologyDrugDextranNanoparticlesPETChemical technologyTP1-1185ArticleTA401-492Materials of engineering and construction. Mechanics of materials

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Impact of administration route on nanocarrier biodistribution in a murine colitis model

10.6084/m9.figshare.21368848Taylor & Francis

Impact of administration route on nanocarrier biodistribution in a murine colitis model

10.6084/m9.figshare.21368848.v1Taylor & Francis

Impact of administration route on nanocarrier biodistribution in a murine colitis model

FAIR Checklist

Authors (10)

Funding (3 grants)

Impact

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)